Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-09-26Clinical Trial Update: Study of EGFR-TKI to Asymptomatic Brain Metastases of NSCLC [Phase 2]
This clinical trial update describes a Phase 2 study evaluating an epidermal growth factor receptor tyrosine kinase inhibitor in patients wi…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation [Phase 3]
A Phase 3 clinical trial comparing erlotinib to gemcitabine/carboplatin in chemo-naive stage IIIB/IV non-small cell lung cancer patients wit…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Feasibility Study of Oral Adjuvant Chemotherapy With S-1 [Phase 2]
A Phase 2 feasibility study evaluated oral adjuvant chemotherapy with S-1 for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. [Phase 2]
This Phase 2 trial evaluated Avastin (bevacizumab) with carboplatin-based chemotherapy in patients with advanced or recurrent non-squamous n…
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
This international study from The Netherlands Cancer Institute investigates using PET/CT in radiotherapy planning for non-small cell lung ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-09-25Clinical Trial Update: Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 2]
This is a Phase 2 clinical trial evaluating chemotherapy tailored to BRCA1 and RRM1 mRNA status in advanced non-small cell lung cancer. The …
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating the combination of AZD2171 (cediranib) and pemetrexed disodium in patients with relapsed non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase 2 study of the HSP90 inhibitor ganetespib (STA-9090) in stage IIIB/IV non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer That Can Be Removed by Surgery [NA]
A completed clinical trial update analyzing whether palliative care improves quality of life and symptom control in patients with resectable…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: GW786034 in Patients With Non Small Cell Lung Cancer 3rd Line [Phase 2]
Phase 2 trial of GW786034 in third-line non-small cell lung cancer was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma [Phase 2]
Phase 2 randomized trial comparing erlotinib to pemetrexed as second-line therapy for advanced non-small cell lung cancer with adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 [Phase 1, Phase 2]
A phase 1/2 study evaluated the maximum tolerated dose, safety, and efficacy of combining docetaxel and cisplatin with STI571 (imatinib) in …
-
CLINICAL_TRIALS research · 2014-09-09Clinical Trial Update: Risk-adapted Stereotactic Body Radiotherapy for Early Non-Small Cell Lung Cancer Using the VERO Stereotactic Body Radio Therapy System [Phase 2]
This clinical trial update describes a Phase II study evaluating risk-adapted stereotactic body radiotherapy for early non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating stereotactic boost therapy for locally advanced non-small cell lung cancer was terminated, with results posted …
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Clinical Impact of EUS in Staging NSCLC
This clinical trial update assesses the clinical impact of endoscopic ultrasound (EUS) in staging non-small cell lung cancer. The study stat…
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating a genomic predictor of platinum resistance to guide therapy in stage IIIB/IV non-small cell lung cancer was termi…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer [Phase 1]
Phase 1 clinical trial update of ABR-217620 in patients with advanced non-small cell lung cancer, renal cell carcinoma, and pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating ABR-217620 in combination with docetaxel for advanced non-small …
-
CLINICAL_TRIALS research · 2014-08-27Clinical Trial Update: Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients [Phase 2]
A Phase 2 clinical trial at Amsterdam UMC evaluating the combination of paclitaxel and trastuzumab in patients with EGFR-mutated, HER2-expre…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: A Study of Management of Tarceva - Induced Rash in Patients With Non-Small Cell Lung Cancer. [Phase 2]
A Phase 2 study evaluating management of Tarceva-induced rash in patients with non-small cell lung cancer has completed, with results posted…
-
FDA approval · 2014-08-26FDA Approved: XALKORI — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for XALKORI (crizotinib) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS research · 2014-08-22Clinical Trial Update: Clinical Observation of S1 Capsule for Stage Ⅱ-ⅢA Non-small Cell Lung Cancer After Complete Resection [Phase 2]
This entry describes a Phase 2 clinical trial evaluating S-1 capsule as adjuvant therapy after complete resection for stage II to IIIA non-s…
-
CLINICAL_TRIALS research · 2014-08-22Clinical Trial Update: Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
This clinical trial update reports the collection of blood samples from patients with non-small cell lung cancer and from healthy volunteers…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers [NA]
A completed clinical trial evaluated cognitive behavioral therapy for anxiety in patients with stage IV non-small cell lung cancer and their…
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Bortezomib in Treating Patients With Stage IIIB or Stage IV Lung Cancer [Phase 2]
Phase 2 clinical trial of bortezomib in patients with Stage IIIB or Stage IV non-small cell lung cancer has completed, with results posted i…